MiRNA has been reported to function as a tumor suppressor in various cancers by targeting multiple oncogenes, including EZH2, and it can inhibit the expression of mRNA by binding to the 3’UTR region of the downstream target gene to suppress translation or degrade mRNA. The gene discussed is EZH2; the disease is cancer.